|
ジユウジヨウ ケンタロウ
Jiyuujiyou Kentarou
重城 健太郎 所属 医学部 医学科（東京女子医科大学病院） 職種 講師 |
|
| 言語種別 | 日本語 |
| 発表タイトル | Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndromes―From Multicenter Cohort Study― |
| 会議名 | 第79回日本循環器学会学術集会 |
| 主催者 | 日本循環器学会 |
| 学会区分 | 全国規模の学会 |
| 発表形式 | ポスター掲示 |
| 講演区分 | 一般 |
| 発表者・共同発表者 | ◎岩朝薫, 大槻尚男, 渡邉真広, 神島一帆, 中尾優, 岡山大, 春木伸太郎, 重城健太郎, 嵐弘之, 南雄一郎, 高木厚, 太田吉実, 森文章, 藤井真也, 本田淳, 山口淳一, 萩原誠久 |
| 発表年月日 | 2015/04/24 |
| 開催地 （都市, 国名） |
大阪市 |
| 概要 | Background: Atrial fibrillation (AF) and acute coronary syndrome (ACS) require multiple antithrombotic agents. The aim of this study is to assess compare the clinical outcome between triple therapy (TT; warfarin + dual anti-platelet therapy [DAPT]) and DAPT.Methods and Results: Consecutive 450 patients with AF undergoing PCI were enrolled at 8 medical centers. Among them 164 patients (36%) presented with ACS. 88(54%) patients on TT and 77(46%) patients on DAPT at the time of PCI. Drug eluting stent was used in 94(57%). The incidence of major adverse cerebro-cardiovascular events (MACCE; cardiac death, non-fatal MI, stroke) and bleeding complications were evaluated. Results are shown below.Conclusion: TT group had higher CHADS2 and HAS-BLED score. The incidence of MACCE was equal but bleeding complications tended to be frequent in TT group. |